Researchers sought to determine whether a reduced dose of apixaban would be as effective as using full-dose apixaban in preventing recurrent VTE in patients with active cancer.

The trial judged the tolerability, safety and efficacy of atogepant, at 60 mg once daily, compared to the highest-tolerated ...

The Filchak family is advocating for FDA approval of elamipretide, an experimental drug that has significantly improved their ...

Come off antidepressants and other mental health medications, and avoid dangerous withdrawal symptoms, by following these ...